A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005)
Clinical trial NCT06104449 · COMPLETED
Trial details
- NCT number
- NCT06104449
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-14
- Primary completion
- 2026-02-20
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.